Sun Pharma may gain on Taro’s performance

Reuters | Updated on January 24, 2018 Published on February 11, 2015

Sun Pharmaceutical Industries’ shares may gain on unit Taro Pharmaceutical Industries’ earnings.

Taro’s margins increased by 70 bps to a record of 81.4 per cent, beating estimates, according to analysts.

Taro says Q3 sales rose 11.3 per cent to $237.7 million.

Sun Pharma’s October-December earnings will beat estimates on account of Taro’s performance, according to traders.

The company will announce quarterly earnings on Saturday, says BSE data.

Published on February 11, 2015
This article is closed for comments.
Please Email the Editor